Engineered Small Extracellular Vesicles as a FGL1/PD‐L1 Dual‐Targeting Delivery System for Alleviating Immune Rejection-Reference-Cited by-同舟云学术

Engineered Small Extracellular Vesicles as a FGL1/PD‐L1 Dual‐Targeting Delivery System for Alleviating Immune Rejection

Published:2021-11-05 Issue:3 Volume:9 Page:2102634
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Tsai Hsiang‐i¹²,Wu Yingyi¹,Liu Xiaoyan¹,Xu Zhanxue¹,Liu Longshan³,Wang Changxi³,Zhang Huanxi³,Huang Yisheng⁴,Wang Linglu¹,Zhang Weixian¹,Su Dandan¹,Khan Fahim Ullah⁵,Zhu Xiaofeng⁶,Yang Rongya⁷,Pang Yuxin⁶,Eriksson John E.⁸,Zhu Haitao²,Wang Dongqing²,Jia Bo⁴,Cheng Fang¹,Chen Hongbo¹^ORCID

Affiliation:

1. School of Pharmaceutical Sciences (Shenzhen) Sun Yat‐sen University Shenzhen 518107 P. R. China

2. Department of Medical Imaging The Affiliated Hospital of Jiangsu University Zhenjiang 212001 China

3. Organ Transplant Center The First Affiliated Hospital Sun Yat‐Sen University 58 Zhongshan 2nd Road Guangzhou Guangdong 510080 China

4. Department of Oral Surgery Stomatological Hospital Southern Medical University Guangzhou Guangdong 510280 P. R China

5. Zoology Department UST Bannu Kp 28100 Pakistan

6. School of Traditional Medicine Materials Resource Guangdong Pharmaceutical University Yunfu Guangdong 527322 China

7. Department of Dermatology The Seventh Medical Center of PLA General Hospital Peking 100010 China

8. Cell Biology Biosciences Faculty of Science and Engineering Åbo Akademi University Turku FI‐20520 Finland

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202102634

Reference55 articles.

1. FK506, An Immunosuppressant Targeting Calcineurin Function

2. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years1

3. A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

4. Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases

5. Organ transplantation—how much of the promise has been realized?

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain as a promising immune checkpoint target for the treatment of SLE;Lupus;2024-01-30

2. Amplifying T cell‐mediated antitumor immune responses in nonsmall cell lung cancer through photodynamic therapy and anti‐PD1;Cell Biochemistry and Function;2024-01

3. Temsirolimus is a promising immunomodulatory agent for enhanced transplantation outcomes;Transplant Immunology;2023-12

4. Dual‐Targeting Nanovesicles Carrying CSF1/CD47 Identified from Single‐Cell Transcriptomics of Innate Immune Cells in Heart Transplant for Alleviating Acute Rejection;Advanced Healthcare Materials;2023-11-30

5. Exosomal miR‐181d‐5p Derived from Rapamycin‐Conditioned MDSC Alleviated Allograft Rejection by Targeting KLF6;Advanced Science;2023-10-23